Singularity Future Technology Ltd. Filing Discloses On Aug. 9, Yang Jie Tendered Resignation From CEO Position

 On August 9, 2022, Mr. Yang Jie tendered his resignation from his positions as the Chief Executive Officer (“CEO”) and director of Singularity Future Technology Ltd. (the “Company”) to the

 On August 9, 2022, Mr. Yang Jie tendered his resignation from his positions as the Chief Executive Officer (“CEO”) and director of Singularity Future Technology Ltd. (the “Company”) to the board of directors of the Company (the “Board”), following the Board’s decision on August 8, 2022, which adopted the Special Committee’s recommendation that Mr. Jie be suspended immediately as the Company’s CEO, pending the Special Committee’s further investigation into allegations raised in the report of Hindenburg Research dated May 5, 2022 and other related matters. 

 

Total
0
Shares
Related Posts
Read More

Acumen Pharmaceuticals Presents Late-Breaker Phase 1 Updates Exploring Novel Target Engagement, Dosing Regimen And Safety Findings For ACU193 In Early Alzheimer’s Disease At The 16th Annual Clinical Trials On Alzheimer’s Disease

- Acumen presented data exploring target engagement modeling of ACU193, the first clinical-stage amyloid beta oligomer (AβO)-targeting antibody, to inform dose selection, plus further analyses of dose-related amyloid

ABOS